Know Cancer

or
forgot password
  • cancer clinical trials in stanford, CA

  • Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Stomach Cancer, Gastro-Esophageal(GE) Junction Cancer, Gastric (Stomach) Cancer, Esophageal Cancer, Gastrointestinal Stromal Tumor (GIST)
    Haploidentical Allogeneic Transplant w/Post Transplant Infusion of Regulatory T-cells (BMT Protocol 204)
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Leukemia, Leukemia Chronic Myelogenous Leukemia (CML), Blood and Marrow Transplant (BMT), Myelodysplastic Syndromes (MDS), Lymphomas: Non-Hodgkin
    Paclitaxel + Bevacizumab (Avastin®) for the Treatment of Metastatic or Unresectable Angiosarcoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Hemangiosarcoma, Soft Tissue Sarcoma
    Phase I Rindopepimut After Conventional Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Brain Cancer, Brain Stem Tumors, Pontine Tumors
    Stanford Accelerated Recovery Trial (START)
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Pain, Breast Cancer, Lung Cancer
    Ovarian Cancer Vaccine for Patients in Remission
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Epithelial Ovarian Cancer
    Immunotherapy Study for Surgically Resected Pancreatic Cancer
    Stanford Cancer Center
    Stanford, California 94305-5824
    Pancreatic Cancer
    A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Liver Cancer
    Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lymphoma, Hodgkin Disease
    Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma
    Stanford University Medical Center Division of Hematology
    Stanford, California 94305-5826
    Relapsed and Bortezomib Refractory Multiple Myeloma, Refractory Multiple Myeloma, Relapsed Multiple Myeloma
    An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
    Stanford Cancer Center
    Stanford, California 94305-5824
    Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin, Acute Myeloid Leukemia, Multiple Myeloma
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Stanford University
    Stanford, California 94305
    Breast Cancer
    Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm
    Stanford University
    Stanford, California 94305
    Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Untreated Adult Acute Myeloid Leukemia, Myeloproliferative Neoplasm With 10% Blasts or Higher
    Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
    Stanford Hospital and Clinics
    Stanford, California 94305
    Chronic GVHD
    Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Bladder Cancer, Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive), Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy), Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable
    Integrated Whole-Genome Analysis of Hematologic Disorders
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Hematologic Diseases
    Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Leukemia
    Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)
    Stanford Hospital and Clinics
    Stanford, California 94305
    Multiple Myeloma
    Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
    Stanford University Medical Center
    Stanford, California 94305-5408
    Peripheral T-cell Lymphoma
    FNA Tumor Sampling for CD137 Modulation: A Pilot Study
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Head and Neck Cancer, Breast Cancer, Head and Neck Cancers
    Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MM
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Multiple Myeloma
    Childhood Cancer Survivor Study
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Cancer
    PI/II of Temozolomide & Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Glioblastoma, Cancer of Brain and Nervous System, Glioblastoma Multiforme
    A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women
    Stanford University
    Stanford, California 94305
    Epithelial Ovarian Cancer
    Imaging and Biomarkers of Hypoxia in Solid Tumors
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Neoplasms
    Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Neuroma, Acoustic
    Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Cutaneous T-cell Lymphoma, Mycosis Fungoides, Sezary Syndrome, Primary Cutaneous Anaplastic Large Cell Lymphoma
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Stanford University
    Stanford, California 94305
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Stem Cell Transplantation, Blood and Marrow Transplant (BMT)
    ZOSTAVAX® in Renal Transplant Patients
    Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases
    Stanford, California 94305-5208
    Herpes Zoster
    Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer, Squamous Cell Carcinoma of the Esophagus, Stage IV Esophageal Cancer
    Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Lymphoma, T-Cell, Peripheral
    Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Myeloproliferative Disorders, Myeloproliferative Disorders (MPD)
    Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Leukemia, Lymphocytic, Leukemia, Myeloid
    Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Pancreatic Cancer
    Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Bone Marrow Transplant Failure, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral
    Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial
    Stanford University
    Stanford, California 94305
    Bladder Cancer Requiring Cystectomy
    Phase I Trial of Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Head and Neck Cancer, Head and Neck Cancers
    Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Neuroendocrine Tumors, Brain (Nervous System) Cancers, Colon/Rectal Cancer, Colon Cancer, Hepatobiliary Cancers, Hepatocellular Carcinoma (Hepatoma), Liver
    Cyberknife Radiosurgery and Quality of Life
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Bone Cancer, Central Nervous System Cancer
    Social Adaptation in Long Term Survivors of Blood and Marrow Transplantation
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Social Adaptation
    Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
    Stanford Cancer Center, Department of Urology
    Stanford, California 94305-5820
    Bladder Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    The Role of Audiovisual Biofeedback on Image Quality During 4D Anatomic and Functional Imaging
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lung Cancer
    A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Locally Advanced or Metastatic Pancreatic Cancer
    Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer
    Early Removal of Urinary Catheters in Patients After Rectal Surgery: a Prospective Study
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Colorectal Cancer
    Natural History Study of SCID Disorders
    Stanford University
    Stanford, California 94305
    SCID, Leaky SCID, Omenn Syndrome, Reticular Dysgenesis, ADA Deficiency, XSCID
    Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Cutaneous Lymphoma, Cutaneous T-cell Lymphoma
    Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
    Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
    Stanford University
    Stanford, California 94305
    Graft vs Host Disease, Cutaneous Sclerosis, Bronchiolitis Obliterans
    Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor
    Stanford University Medical Center
    Stanford, California 94305-5408
    Pigmented Villonodular Synovitis, Diffuse-type Giant Cell Tumor, Tenosynovial Giant Cell Tumor
    Nephrotic Syndrome Study Network
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Minimal Change Disease (MCD), Membranous Nephropathy, Glomerulosclerosis, Focal Segmental
    Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
    Stanford University
    Stanford, California 94305
    Amyloidosis
    Evaluation of the Cook Biodesign Plastic Surgery Matrix
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer, Breast Reconstruction, Nipple Reconstruction
    Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
    Stanford University Medical Center Cancer Clinical Trials Office
    Stanford, California 94304
    Metastatic Renal Cell Carcinoma
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Safety and Efficacy of PCI-32765 in Subjects With Relapsed/Refractory Mantle Cell Lymphoma (MCL)
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Mantle Cell Lymphoma
    Extension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)
    Stanford Cancer Center
    Stanford, California 94305-5824
    Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis
    GDC-0449 in Treating Younger Patients With Recurrent or Refractory Medulloblastoma
    Stanford University
    Stanford, California 94305
    Recurrent Childhood Medulloblastoma
    The Adv Halt Trial
    Lucile Packard Childrens hopsital at Stanford
    Stanford, California 94304
    Adenovirus Disease
    Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
    Stanford Cancer Center
    Stanford, California 94305-5824
    Myelodysplastic Syndromes, MDS, RAEB, Chronic Myelomonocytic Leukemia
    Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
    Stanford University Medical Center Stanford U
    Stanford, California 94304
    Acute Myeloid Leukemia (AML)